ABSTRACT
Objective:To establish the biology reference interval (RI) of peripheral blood procalcitonin (PCT) for children between 3 days and 6 years old in China.Methods:Totally 3 353 reference individuals with apparent health or no specific diseases were recruited in 18 hospitals throughout the country during October 2020 to May 2021. Reference individuals were divided into four groups: 3-28 days, 29 days - 1 year, 1-3 years and 4-6 years. Vein blood or capillary blood were collected by percutaneous puncture from every reference individual. The PCT level in serum and the capillary whole blood were assayed by Roche Cobas e601 and Norman NRM411-S7 immunoanalyzer. Outliers were deleted and 95th percentiles of every group were provided as RIs. Man-Whitney U test or Kruskal-Wallis test were used performed to assess the difference among different gender, age or method groups. Results:The difference of PCT distribution between male and female is not statistically significant, but the difference between serum and capillary whole blood is statistically significant. The differences between age groups are significant too. For Roche e601, serum PCT RI of 3-28 days group is <0.23 μg/L, 29 days - 6 years are <0.11 μg/L. For NRM411, Serum PCT RI of 3-28 days group is <0.21 μg/L, 29 days - 1 year: <0.09 μg/L, 1 - 6 years: <0.10 μg/L. For whole blood PCT, RI of 3-28 days group is <0.26 μg/L, 29 days - 6 years is <0.15 μg/L.Conclusions:Serum and capillary whole blood PCT have different RIs, however, capillary whole blood PCT testing is valuable in pediatric application. Children in 3-28 days show higher PCT levels than other age group. To establish the RIs and understand the differences among different groups are essential for the interpretation and clinical application of peripheral blood PCT testing results.
ABSTRACT
Objective:To explore the performance of the commonly used whole blood C-reactive protein (CRP) detection systems and give related recommendation on the performance requirements of detection systems.Methods:A total of 7 540 venous blood samples from 26 maternal, child and children′s hospitals were collected to conduct this multi-center study on the analytical performance of 5 commonly used whole blood CRP detection systems from March to April in 2019. The blank check, carryover, repeatability, intermediate precision, linearity, sample stability, influence of hematocrit/triglyceride/bilirubin, comparison with SIEMENS specific protein analyzer and trueness were evaluated. The 5 systems included BC-5390CRP autohematology analyzer, AstepPLUS specific protein analyzer, Ottoman-1000 Automated Specific Protein POCT Workstation, i-CHROMA Immunofluorometer equipment Reader and Orion QuikRead go detecting instrument. The 5 systems were labeled as a, b, c, d and e randomly.Results:Within the 5 systems, all values of blank check were less than 1.00 mg/L, the carryovers were lower than 1.00%. The repeatability of different ranges of CRP concentrations including 3.00-10.00, 10.00-30.00 and>30.00 mg/L were less than 10.00%, 6.00% and 5.00%, respectively, and the intermediate precision was less than 10.00%. The linearity correlation coefficients of the 5 systems were all above 0.975, while the slope was within 0.950-1.050. Whole blood samples were stable within 72 hours both at room temperature (18-25 ℃) and refrigerated temperature (2-8 ℃). The CRP results were rarely influenced by high triglyceride or bilirubin, except for the immmunoturbidimetric test based on microparticles coated with anti-human CRP F(ab) 2 fragments. When triglyceride was less than 15.46 mmol/L, the deviation of CRP was less than 10.00%. When bilirubin was less than 345.47 μmol/L, the deviation of CRP was less than 10.00%. CRP was more susceptible to Hct on the systems without Hct correction. The deviation of CRP between different Hct dilution concentration and 40% dilution concentration can reach as high as 67.48%. The correlation coefficients ( r) of 5 systems were all more than 0.975 in the range of 0-300.00 mg/L compared with Siemens specific protein analyzer. All systems passed the trueness verification using the samples with specified values of 12.89 and 30.60 mg/L. Conclusion:The performance of 5 systems can basically meet the clinical needs, but it is suggested that the whole blood CRP detection system without automatic Hct correction should be modified manually.
ABSTRACT
Objective To explore the cause of bile acid-induced lung injury through investigating the cell apoptosis and the expressions of Capsase-3 in A549 cell of umbilical artery serum in neonates delivered by women with intrahepatic cholestasis of pregnancy.Methods A549 cell was used as target cell.The cultural cells in orifice were divided into control group and intrahepatic cholestasis of pregnancy-serum attacking group.The cells of control group were cultivated with normal nutritive medium.The umbilical arterial blood was cowered from the placental end of pregnant women with intrahepatic cholestasis after the baby had been delivered.Then the serum was gathered,and the cells of the intrahepatic cholestasis of pregnancy-serum attacking group were attacked by intrahepatic cholestasis of pregnancyserum.After 24 hours,lactate dehydrogenase leakage rate,expression of Caspase-3 and the apoptosis rate of the cells in the 2 groups were detected,respectively.Results The expression of Caspase-3 in A549 cells was observed in the light microscope,and Caspase-3 expre-ssion in the cytoplasm was brown.The lactate dehydrogenase leakage rate [(34.68 ±0.77) ％],the integrate optical density value (981.77 ± 55.21) of the expression of Caspase-3 and the rate of apoptosis [(27.86 ± 0.53) ％] of cells in intrahepatic cholestasis of pregnancy group were significantly higher than those of the cells in control group[(17.39±0.66)％,(540.63 ±38.41),(6.99 ±0.11)％] (t =-45.70,-15.96,-134.41,all P ＜ 0.05).Conclusions Umbilical artery serum in neonates delivered by women with intrahepatic cholestasis of pregnancy can induce apoptosis of A549 cells by up-regulating the expression of Caspase-3,and this was the potential machine of bile acid-induced lung injury in newborn infants.